Evidence map›Paper›PMID 19587778›Full record

ArticlePloS one2009

The Schizosaccharomyces pombe checkpoint kinases Chk1 and Cds1 are important for cell survival in response to cisplatin.

Domenica Paparatto, Dane Fletcher, Karen Piwowar, Kimberly Baldino, Charlotte Morel, Stephen Dunaway

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Domenica PaparattoDepartment of Biology, Drew University, Madison, New Jersey, USA.
Dane Fletcher
Karen Piwowar
Kimberly Baldino
Charlotte Morel
Stephen Dunaway
Drew University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDNA damage checkpoints insure that the integrity of genomic DNA is faithfully maintained throughout the eukaryotic cell cycle. In the presence of damaged DNA, checkpoints are triggered to delay cell cycle progression to allow for DNA repair. In fission yeast, the kinases Chk1 and Cds1 are major components of these DNA damage checkpoint pathways. Both Chk1 and Cds1 are important for viability in the presence of several DNA damaging agents. In this study we hypothesized that Chk1 and Cds1 play a vital role in fission yeast cells ability to survive exposure to the DNA damaging agent cisplatin. Cisplatin is a potent chemotherapeutic drug that interacts with DNA and causes both inter- and intra-strand DNA cross-links. METHODOLOGY/PRINCIPAL

findingsHere, we demonstrated that treatment with cisplatin in fission yeast causes a Chk1-dependent DNA damage signal. chk1(-) cells were sensitive to cisplatin and Chk1 was phosphorylated in response to cisplatin treatment. We also showed that a Chk1-dependent DNA damage checkpoint pathway is activated in a dose-dependent fashion in cells challenged with cisplatin. Furthermore the Cds1 checkpoint kinase was also important for viability in cisplatin challenged cells. In cds1(-) cells, cisplatin treatment reduced cell viability and this phenotype was exacerbated in a chk1(-)/cds1(-) background. CONCLUSIONS/SIGNIFICANCE: Thus, we conclude that the concerted effort of both major checkpoint kinases in fission yeast, Chk1 and Cds1, protect cells from cisplatin induced DNA damage. These observations are significant because they suggest that various classes of inter-strand crosslinking agents may generate slightly different lesions as work by others did not observe loss of viability in cds1(-) cells treated with other crosslinking agents like nitrogen mustard.

Indexed as

Antineoplastic AgentsBlotting, WesternCell SurvivalCheckpoint Kinase 1Checkpoint Kinase 2CisplatinDNA DamageElectrophoresis, Polyacrylamide GelPhosphorylationProtein KinasesProtein Serine-Threonine KinasesSchizosaccharomyces pombe ProteinsAntineoplastic AgentsCds1 protein, S pombeCheckpoint Kinase 1Checkpoint Kinase 2Chk1 protein, S pombeCisplatinProtein KinasesProtein Serine-Threonine KinasesSchizosaccharomyces pombe Proteins

Identifiers

PMID19587778
PMCPMC2702685
OpenAlexW2025102101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.